Hi guys, label #1:1 attr structure.vdx_Registration_Number offset -10,-10,1 height 2. I have this working after a I read in a *.mol2 file and attached the attributes to each structure. Can I have additional attributes displayed alongside from the same attribute list? Thanks Krish -----Original Message----- From: Elaine Meng <meng@cgl.ucsf.edu> Sent: Tuesday, May 28, 2024 3:35 PM To: Krishnan Raman <RKrishnan@BIOCRYST.com> Cc: chimerax-users@cgl.ucsf.edu Subject: Re: [chimerax-users] attributes from viewdockx. [EXTERNAL] Hi Krish, See the "label" command and its "attribute" option: <https://link.edgepilot.com/s/1dea9e8c/lZKXJdUqZECgkgm0ow-M2w?u=https://rbvi....> <https://link.edgepilot.com/s/47edf4aa/QQV5o3jY1k_07gWSHFARAA?u=https://rbvi....> There are several examples in the explanation of the option, .e.g.: label /A:1 residues attr structure.name height 5 offset 1,1,1 I hope this helps, Elaine ----- Elaine C. Meng, Ph.D. UCSF Chimera(X) team Resource for Biocomputing, Visualization, and Informatics Department of Pharmaceutical Chemistry University of California, San Francisco
On May 28, 2024, at 1:21 PM, Krishnan Raman via ChimeraX-users <chimerax-users@cgl.ucsf.edu> wrote:
Hi guys, • Make ViewDockX table information available as model attributes. December 17, 2021 Used this Py to register my attributes into chimerax. Is there a way to display the attributes next to the model of the ligand? Thanks Krish
Links contained in this email have been replaced. If you click on a link in the email above, the link will be analyzed for known threats. If a known threat is found, you will not be able to proceed to the destination. If suspicious content is detected, you will see a warning. CONFIDENTIALITY NOTICE This email, including any attachments, may contain confidential or legally privileged information that is intended only for the individual or entity to whom it is addressed. If you are not the intended recipient, please be advised that any dissemination, distribution or copying of this email and any attachment is strictly prohibited. If you have received this email in error, please reply to the sender so that BioCryst Pharmaceuticals, Inc. can take corrective measures and then permanently delete this email and any attachment, including any printed copies. Thank you.